3D Structure Inspector
Structure Overview
Ligand Interactions

4HMA - Overview - 3D Structure Inspector

Atoms
Solvent
Spheres
Surface
Colour
Opacity
Texture
Background

LeftMouse Rotate
Shift+Left Scale
Ctrl+Left Translate
Click Select
+,− Clipping
r Reset view

AstexViewer™ Copyright (C) 1999-2007 Astex Therapeutics Ltd.
OpenAstexViewer Copyright (C) 2007-2014 Mike Hartshorn





Display Compound Structure Het Het Names Het Formula
PEG
DI(HYDROXYETHYL)ETHER
PEG
DI(HYDROXYETHYL)ETHER
C4 H10 O3
0ZD
0ZD
N,N'-bis(2-[(biphenyl-4ylsulfonyl)[(2R)-1-hydroxy-...
C46 H50 N4 O10 S2
GOL
CRY
E422
GLYCERIN
GOL
Glycerin
Glycerol
Glycogelatin
Keybells
MONOCTANOIN COMPONENT D
Monoctanoin Component D
Nirolex
Ophthalgan
Optim
Osmoglyn
Procalamine
Senokot Direct Relief
Tixylix Baby
Tixylix Toddler
Waterhouse
GLYCEROL
C3 H8 O3
MLT
(R)-2-Hydroxysuccinic Acid
DMR
MLT
D-MALATE
C4 H6 O5
CA
/CA
CA
CALCIUM ION
Ca
ZN
/ZN
ZINC ION
ZN
ZN2
ZINC ION
Zn
PDB Code4HMA
TitleCRYSTAL STRUCTURE OF AN MMP TWIN CARBOXYLATE BASED INHIBITOR LC20 IN COMPLEX WITH THE MMP-9 CATALYTIC DOMAIN
Deposition
Release
Last Modified
ObsoleteNo
ClassificationHYDROLASE/HYDROLASE INHIBITOR
Experiment TypeX-RAY DIFFRACTION
Space GroupP 21 21 2
Resol Range High1.94
Resol Range Low50
Pubmed Id23567804
Doi10.1016/J.JSB.2013.03.015
PDB Chain4HMA_A (click to show/hide)
PDB Chain4HMA_B (click to show/hide)